Director LORBRENA/Lung Marketing
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
The Lung cancer portfolio is one of the fastest growing portfolios in Pfizer Oncology and includes the following brands: LORBRENA, BRAFTOVI/MEKTOVI Lung, XALKORI and VIZIMPRO. Lung cancer is the most common cancer, and LORBRENA, our ALK+ inhibitor has been prescribed to over 12,000 patients since launching in the US in 2018. At ASCO 2024, the unprecedented 5-year follow analysis of the pivotal Phase 3 CROWN trial was presented and published. This practice-changing data is expected to solidify LORBRENA’s position in treating patients with ALK+ metastatic non-small cell lung cancer (NSCLC). The Director LORBRENA/Lung Marketing position will report to the US Lung Team Lead and will be responsible for leading the development and execution of LORBRENA’s patient strategy and tactics, co-creating promotional pieces in close collaboration with the LORBRENA HCP strategy lead, and working across the lung portfolio to lead field-based analytics and engagement. Activities associated with this position include strategic marketing, tactic planning, data & analytics. The Director will work closely with internal and external partners, including sales, market insights, Regulatory, Legal, Medical Affairs, TLELs, Advocacy, other members of the brand team, and agencies.
